SummerHaven Investment Management LLC Increases Holdings in Enhabit, Inc. (NYSE:EHAB)

SummerHaven Investment Management LLC increased its stake in Enhabit, Inc. (NYSE:EHAB) by 1.8% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 58,947 shares of the company’s stock after buying an additional 1,038 shares during the period. SummerHaven Investment Management LLC’s holdings in Enhabit were worth $610,000 as of its most recent filing with the SEC.

Several other institutional investors also recently added to or reduced their stakes in EHAB. Quantbot Technologies LP purchased a new position in Enhabit in the third quarter valued at about $73,000. Louisiana State Employees Retirement System bought a new position in Enhabit during the fourth quarter valued at $260,000. Brooks Moore & Associates Inc. increased its position in Enhabit by 5.1% in the third quarter. Brooks Moore & Associates Inc. now owns 26,950 shares of the company’s stock worth $303,000 after buying an additional 1,300 shares during the last quarter. HighTower Advisors LLC bought a new stake in shares of Enhabit in the third quarter valued at $310,000. Finally, Illinois Municipal Retirement Fund purchased a new position in shares of Enhabit during the 3rd quarter valued at $334,000.

Enhabit Stock Up 2.8 %

Shares of Enhabit stock opened at $10.31 on Tuesday. The company’s 50-day moving average price is $10.30 and its 200-day moving average price is $9.94. Enhabit, Inc. has a 12-month low of $7.12 and a 12-month high of $14.59. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.53 and a quick ratio of 1.53.

Enhabit (NYSE:EHAB) last released its quarterly earnings results on Wednesday, March 6th. The company reported $0.03 EPS for the quarter, beating analysts’ consensus estimates of $0.02 by $0.01. Enhabit had a negative net margin of 7.69% and a positive return on equity of 1.55%. The firm had revenue of $260.60 million during the quarter, compared to analyst estimates of $260.30 million. During the same period in the previous year, the business earned $0.32 EPS. As a group, research analysts expect that Enhabit, Inc. will post 0.24 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the company. Oppenheimer reissued a “market perform” rating on shares of Enhabit in a report on Thursday, March 7th. UBS Group raised shares of Enhabit from a “sell” rating to a “neutral” rating and set a $9.50 price target on the stock in a research report on Thursday, March 7th. Finally, Jefferies Financial Group cut their price objective on shares of Enhabit from $15.00 to $14.00 and set a “buy” rating for the company in a report on Wednesday, March 6th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $12.08.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.